<?xml version='1.0' encoding='utf-8'?>
<document id="23204627"><sentence text="Prevalence of potential drug interactions in an Iranian general hospital." /><sentence text="The hazards of prescribing many drugs, including side-effects, drug-drug interactions and difficulties of compliance have long been recognized as particular problems when prescribing" /><sentence text=" This study estimates the rate and factors associated with potential drug-drug interactions in prescriptions from wards of An Iranian General Hospital" /><sentence text=" Data were retrieved from the pharmacy of a general hospital (200 beds) during one year period 2010" /><sentence text=" Potential drug-drug interaction were identified using a computerized drug-drug interaction database system (Prescription Analyzer 2000, Sara Rayane Co" /><sentence text=", Iran)" /><sentence text=" Patients of both genders and 15 years-old or more were included in this study" /><sentence text=" Prescriptions with two or more drugs prescribed were selected during one year period 2010" /><sentence text=" Gender number of drugs and therapeutic drug classes on prescriptions were explored as associated factors to drug-drug interaction" /><sentence text=" The overall prevalence of potential drug-drug interaction was 20" /><sentence text="3%" /><sentence text=" The risks of severe potential drug interactions were relatively high and the rate of potential drug-drug interaction was significantly higher in women (60" /><sentence text="6%) and the patients aged over 60 years old (57" /><sentence text="1%)" /><sentence text=" The frequency of the potentially severe drug-drug interaction was 10" /><sentence text="8% with digoxin-furosemide as the most common interacting pair (5"><entity charOffset="8-15" id="DDI-PubMed.23204627.s16.e0" text="digoxin" /></sentence><sentence text="91%)" /><sentence text=" A positive correlation was found between drug-drug interaction, patient's age, number of drugs and drugs acting on cardiovascular system" /><sentence text=" So cardiology women inpatients, age more then 60 years old, and patients prescribed digoxin and angiotensin-converting enzyme inhibitors should be closely monitored for adverse outcomes from drug-drug interaction"><entity charOffset="85-92" id="DDI-PubMed.23204627.s19.e0" text="digoxin" /><entity charOffset="97-108" id="DDI-PubMed.23204627.s19.e1" text="angiotensin" /><pair ddi="false" e1="DDI-PubMed.23204627.s19.e0" e2="DDI-PubMed.23204627.s19.e0" /><pair ddi="false" e1="DDI-PubMed.23204627.s19.e0" e2="DDI-PubMed.23204627.s19.e1" /></sentence><sentence text="" /></document>